Literature DB >> 25516696

Overview of insulin and non-insulin delivery devices in the treatment of diabetes.

Michele Pisano.   

Abstract

Antidiabetic agents can be delivered orally or with a syringe, but other options are also available, such as insulin and non-insulin pen devices and insulin pumps. This article reviews the available delivery devices and their current place in therapy.

Entities:  

Year:  2014        PMID: 25516696      PMCID: PMC4264673     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


  23 in total

1.  Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

2.  Nurse satisfaction using insulin pens in hospitalized patients.

Authors:  Estella M Davis; Anne Bebee; Leaanne Crawford; Chris Destache
Journal:  Diabetes Educ       Date:  2009-07-24       Impact factor: 2.140

3.  A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens.

Authors:  Hans Hemmingsen; Marcus Niemeyer; Marianne Rye Hansen; Ditlef Bucher; Niels Bjerrum Thomsen
Journal:  Diabetes Technol Ther       Date:  2011-08-24       Impact factor: 6.118

4.  Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.

Authors:  David Cobden; Won Chan Lee; Sanjeev Balu; Ashish V Joshi; Chris L Pashos
Journal:  Pharmacotherapy       Date:  2007-07       Impact factor: 4.705

5.  Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization.

Authors:  Estella M Davis; Carla M Christensen; Kelly K Nystrom; Pamela A Foral; Chris Destache
Journal:  Am J Health Syst Pharm       Date:  2008-07-15       Impact factor: 2.637

6.  A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.

Authors:  Mary Korytkowski; David Bell; Carol Jacobsen; Rudee Suwannasari
Journal:  Clin Ther       Date:  2003-11       Impact factor: 3.393

Review 7.  Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability.

Authors:  Alan J Garber
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

8.  Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006.

Authors:  Ninh T Nguyen; Xuan-Mai T Nguyen; John Lane; Ping Wang
Journal:  Obes Surg       Date:  2011-03       Impact factor: 4.129

Review 9.  Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2012-04-19       Impact factor: 19.112

10.  Correlates of insulin injection omission.

Authors:  Mark Peyrot; Richard R Rubin; Davida F Kruger; Luther B Travis
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

View more
  6 in total

1.  Tissue Response to Subcutaneous Infusion Catheter.

Authors:  Ershuai Zhang; Zhiqiang Cao
Journal:  J Diabetes Sci Technol       Date:  2019-03-31

Review 2.  Mechanism of cardiovascular disease benefit of glucagon-like peptide 1 agonists.

Authors:  Josh Reed; Venkateswarlu Kanamarlapudi; Stephen Bain
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-02-14

3.  Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered via Continuous Subcutaneous Insulin Infusion Versus Subcutaneous Injection in Adults With Type 2 Diabetes and High-Dose Insulin Requirements.

Authors:  Xiaosu Ma; Charles T Benson; Randy Prescilla; Shuyu Zhang; Helle Linnebjerg; Elizabeth S LaBell; Linda A Morrow; Jeffrey A Jackson; Alex Nguyen; Liza L Ilag; Jennal L Johnson; Derek Leishman
Journal:  J Diabetes Sci Technol       Date:  2020-11-26

Review 4.  Developing Insulin Delivery Devices with Glucose Responsiveness.

Authors:  Zejun Wang; Jinqiang Wang; Anna R Kahkoska; John B Buse; Zhen Gu
Journal:  Trends Pharmacol Sci       Date:  2020-11-26       Impact factor: 14.819

Review 5.  Digital Diabetes Management: A Literature Review of Smart Insulin Pens.

Authors:  Lutz Heinemann; Oliver Schnell; Bernhard Gehr; Nanette C Schloot; Sven W Görgens; Christoph Görgen
Journal:  J Diabetes Sci Technol       Date:  2021-01-11

Review 6.  Forum for Injection Technique and Therapy Expert Recommendations, India: The Indian Recommendations for Best Practice in Insulin Injection Technique, 2017.

Authors:  Nikhil Tandon; Sanjay Kalra; Yatan Pal Singh Balhara; Manash P Baruah; Manoj Chadha; Hemraj B Chandalia; K M Prasanna Kumar; S V Madhu; Ambrish Mithal; Rakesh Sahay; Rishi Shukla; Annamalai Sundaram; Ambika G Unnikrishnan; Banshi Saboo; Vandita Gupta; Subhankar Chowdhury; Jothydev Kesavadev; Subhash K Wangnoo
Journal:  Indian J Endocrinol Metab       Date:  2017 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.